Advertisement
Advertisement
U.S. Markets close in 2 hrs 34 mins
Advertisement
Advertisement
Advertisement
Advertisement

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.4452+0.2152 (+5.09%)
As of 01:24PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 2.25
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 317.2500
52 Week Low 34.2200
50-Day Moving Average 35.5952
200-Day Moving Average 37.3776

Share Statistics

Avg Vol (3 month) 35.52M
Avg Vol (10 day) 34.57M
Shares Outstanding 5306.34M
Implied Shares Outstanding 6N/A
Float 8276.34M
% Held by Insiders 16.35%
% Held by Institutions 124.44%
Shares Short (Dec 14, 2021) 444.15M
Short Ratio (Dec 14, 2021) 47.37
Short % of Float (Dec 14, 2021) 414.64%
Short % of Shares Outstanding (Dec 14, 2021) 414.41%
Shares Short (prior month Nov 14, 2021) 445.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Jul 31, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-643.89%

Management Effectiveness

Return on Assets (ttm)-30.49%
Return on Equity (ttm)-258.42%

Income Statement

Revenue (ttm)51.33M
Revenue Per Share (ttm)0.18
Quarterly Revenue Growth (yoy)2.60%
Gross Profit (ttm)-81.29M
EBITDA -318.71M
Net Income Avi to Common (ttm)-355.41M
Diluted EPS (ttm)-1.2490
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)162.67M
Total Cash Per Share (mrq)0.54
Total Debt (mrq)202.56M
Total Debt/Equity (mrq)154.24
Current Ratio (mrq)1.15
Book Value Per Share (mrq)0.44

Cash Flow Statement

Operating Cash Flow (ttm)-250.55M
Levered Free Cash Flow (ttm)-109.08M
Advertisement
Advertisement